Michael C. Sabel
Duesseldorf, NW 40225, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Multiomics and spatial mapping characterizes human CD8+ T cell states in cancer.
Journal: Science translational medicine
Published: April 12, 2023
Lymph node and tumor-associated PD-L1+ macrophages antagonize dendritic cell vaccines by suppressing CD8+ T cells.
Journal: Cell reports. Medicine
Published: August 22, 2022
Letter to the Editor Regarding "A Novel Wavelength-Specific Blue Light-Emitting Headlamp for 5-Aminolevulinic Acid Fluorescence-Guided Resection of Glioblastoma".
Journal: World neurosurgery
Published: August 28, 2019
Treatment-Related Uptake of O-(2-18F-Fluoroethyl)-l-Tyrosine and l-[Methyl-3H]-Methionine After Tumor Resection in Rat Glioma Models.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 02, 2019
Accumulation of protoporphyrin IX in medulloblastoma cell lines and sensitivity to subsequent photodynamic treatment.
Journal: Journal of photochemistry and photobiology. B, Biology
Published: September 13, 2018
Human glioblastoma stem-like cells accumulate protoporphyrin IX when subjected to exogenous 5-aminolaevulinic acid, rendering them sensitive to photodynamic treatment.
Journal: Journal of photochemistry and photobiology. B, Biology
Published: July 05, 2016
Prognostic relevance of miRNA-155 methylation in anaplastic glioma.
Journal: Oncotarget
Published: May 09, 2016
Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide.
Journal: Neuro-oncology
Published: March 28, 2016
Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial.
Journal: Neuro-oncology
Published: November 08, 2015
MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 28, 2014
Genomic profiling reveals distinctive molecular relapse patterns in IDH1/2 wild-type glioblastoma.
Journal: Genes, chromosomes & cancer
Published: February 17, 2014
Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling.
Journal: International journal of cancer
Published: December 27, 2013
Last Updated: 09/26/2026